| Shrihari S Kadkol, | |
|
1740 W Taylor St, Chicago, IL 60612-7232 | |
| (866) 600-2273 | |
| Not Available |
| Full Name | Shrihari S Kadkol |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 36 Years |
| Location | 1740 W Taylor St, Chicago, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073525994 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0105X | Pathology - Clinical Pathology/laboratory Medicine | 036087484 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Illinois Hospital | Chicago, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Board Of Trustees Of The University Of Illinois | 3072422716 | 929 |
News Archive
In the search for new drugs to treat neglected diseases and malaria, researchers at the University of Campinas and University of Sao Paulo will assemble a team of scientists in a global collaboration network co-funded by the São Paulo Research Foundation, the Drugs for Neglected Diseases initiative and the Medicines for Malaria Venture.
Phenolic compounds in olive oil, which have antioxidant, anti-inflammatory and anti-clotting properties, may explain cardiovascular health benefits associated with the so-called Mediterranean Diet, according to a new study in the Nov. 15, 2005, issue of the Journal of the American College of Cardiology.
Amgen today announced that a pivotal, Phase 3, head-to-head trial evaluating denosumab versus Zometa® (zoledronic acid) in the treatment of bone metastases in 1,901 men with advanced prostate cancer met its primary and secondary endpoints.
While children of all ethnicities can contract Kawasaki disease (KD), a study led by researchers at the Kawasaki Disease Research Center at the University of California, San Diego and Rady Children's Hospital-San Diego finds that Filipino children with KD are at a higher risk for inflammation of the blood vessels of the heart than those of other Asian and non-Asian backgrounds.
Vivakor, Inc. announced today that the Company has engaged IME Capital to structure joint venture relationships for its VIVASLICES MRI technology. Vivakor Inc. has also engaged its board member John Gryga, former GE Healthcare Executive, to act as lead on all transactions for VIVASLICES.
› Verified 8 days ago
| Entity Name | The Board Of Trustees Of The University Of Illinois |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386863819 PECOS PAC ID: 3072422716 Enrollment ID: O20031112000158 |
News Archive
In the search for new drugs to treat neglected diseases and malaria, researchers at the University of Campinas and University of Sao Paulo will assemble a team of scientists in a global collaboration network co-funded by the São Paulo Research Foundation, the Drugs for Neglected Diseases initiative and the Medicines for Malaria Venture.
Phenolic compounds in olive oil, which have antioxidant, anti-inflammatory and anti-clotting properties, may explain cardiovascular health benefits associated with the so-called Mediterranean Diet, according to a new study in the Nov. 15, 2005, issue of the Journal of the American College of Cardiology.
Amgen today announced that a pivotal, Phase 3, head-to-head trial evaluating denosumab versus Zometa® (zoledronic acid) in the treatment of bone metastases in 1,901 men with advanced prostate cancer met its primary and secondary endpoints.
While children of all ethnicities can contract Kawasaki disease (KD), a study led by researchers at the Kawasaki Disease Research Center at the University of California, San Diego and Rady Children's Hospital-San Diego finds that Filipino children with KD are at a higher risk for inflammation of the blood vessels of the heart than those of other Asian and non-Asian backgrounds.
Vivakor, Inc. announced today that the Company has engaged IME Capital to structure joint venture relationships for its VIVASLICES MRI technology. Vivakor Inc. has also engaged its board member John Gryga, former GE Healthcare Executive, to act as lead on all transactions for VIVASLICES.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shrihari S Kadkol, 809 S Marshfield Ave, 9th Floor (m/c 732), Chicago, IL 60612-4305 Ph: (312) 996-7699 | Shrihari S Kadkol, 1740 W Taylor St, Chicago, IL 60612-7232 Ph: (866) 600-2273 |
News Archive
In the search for new drugs to treat neglected diseases and malaria, researchers at the University of Campinas and University of Sao Paulo will assemble a team of scientists in a global collaboration network co-funded by the São Paulo Research Foundation, the Drugs for Neglected Diseases initiative and the Medicines for Malaria Venture.
Phenolic compounds in olive oil, which have antioxidant, anti-inflammatory and anti-clotting properties, may explain cardiovascular health benefits associated with the so-called Mediterranean Diet, according to a new study in the Nov. 15, 2005, issue of the Journal of the American College of Cardiology.
Amgen today announced that a pivotal, Phase 3, head-to-head trial evaluating denosumab versus Zometa® (zoledronic acid) in the treatment of bone metastases in 1,901 men with advanced prostate cancer met its primary and secondary endpoints.
While children of all ethnicities can contract Kawasaki disease (KD), a study led by researchers at the Kawasaki Disease Research Center at the University of California, San Diego and Rady Children's Hospital-San Diego finds that Filipino children with KD are at a higher risk for inflammation of the blood vessels of the heart than those of other Asian and non-Asian backgrounds.
Vivakor, Inc. announced today that the Company has engaged IME Capital to structure joint venture relationships for its VIVASLICES MRI technology. Vivakor Inc. has also engaged its board member John Gryga, former GE Healthcare Executive, to act as lead on all transactions for VIVASLICES.
› Verified 8 days ago
Mark Wang, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 251 E Huron St, Feinberg Pavilion, Chicago, IL 60611 Phone: 312-503-8144 Fax: 312-502-8249 | |
Sandeep Gurbuxani, Pathology Medicare: Accepting Medicare Assignments Practice Location: 5841 S Maryland Ave, Chicago, IL 60637 Phone: 888-824-0200 | |
Dr. Katrina Krogh, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 251 E Huron St Ste 7-132i, Chicago, IL 60611 Phone: 312-926-7913 Fax: 312-926-3127 | |
Dr. Carmencita Garcia Senseng, MD Pathology Medicare: Medicare Enrolled Practice Location: 1900 W Polk St, Chicago, IL 60612 Phone: 312-864-7561 | |
Suman Setty, Pathology Medicare: Accepting Medicare Assignments Practice Location: 1740 W Taylor St, Chicago, IL 60612 Phone: 866-600-2273 | |
Jayme Brentan, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 680 N Lake Shore Dr, Suite 1000, Chicago, IL 60611 Phone: 312-695-9797 | |
Dr. Megan Elizabeth Sullivan, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 680 N Lake Shore Dr, Suite 1000, Chicago, IL 60611 Phone: 312-926-3211 |